Clearance of fentanyl, alfentanil, methohexitone, thiopentone and ketamine in relation to estimated hepatic blood flow in several animal species: Application to prediction of clearance in man

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 9, 2000, Pages 1065-1074

  Bjorkman, S ^a   Redke, F ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL; KETAMINE; METHOHEXITAL; THIOPENTAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISTRIBUTION VOLUME; DRUG CLEARANCE; EXPERIMENTAL MODEL; HUMAN; HUMAN TISSUE; LIVER BLOOD FLOW; MALE; NONHUMAN; PLASMA; PLASMA CLEARANCE; RABBIT; RAT; SWINE;

EID: 0033804031     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774985     Document Type: Article

References (44)

1. 2 reactivity in pigs anaesthetized with fentanyl, nitrous oxide and pancuronium
2. Effect of premedication with acetylpromazine on the disposition kinetics of thiopental
3. Influence of Escherichia coli endotoxin on the pharmacokinetics and respiratory depressant effect of alfentanil in rabbits
4. Simultaneous determination of fentanyl and alfentanil in rat tissues by capillary column gas chromatography
5. Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats
6. Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: An application of mass balance pharmacokinetics with a changing regional blood flow
7. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients
8. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
9. Interspecies pharmacokinetic scaling, biological design and neoteny
10. The pharmacokinetics of thiopentone
11. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay
12. Ketamine kinetics in unmedicated and diazepam-premedicated subjects
13. From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopental disposition in the rat
14. The relationship between alfentanil distribution kinetics and cardiac output
15. Pharmacokinetics of methohexital and thiopental in surgical patients
16. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery
17. Comparative study of the pharmacokinetics of alfentanil in rabbits, sheep, and dogs
18. A comparative study of the pharmacokinetics of thiopental in the rabbit, sheep and dog
19. Thiopental disposition in lean and obese patients undergoing surgery
20. Pharmacokinetics of ketamine and two metabolites in the dog
21. Pharmacokinetic-pharmacodynamic modeling in drug development: Application to the investigational opioid trefentanil
22. Pharmacokinetics and haemodynamic effects of prolonged methohexitone infusion
23. Correlation between drug and metabolite concentrations in plasma and anesthetic action ketamine in swine
24. Interspecies scaling: Predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance
25. Interspecies scaling: Predicting clearance of drugs in humans. Three different approaches
26. Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species
27. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols
28. Population pharmacokinetics of alfentanil: The average dose-plasma concentration relationship and interindividual variability in patients
29. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat
30. Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood
31. Pharmacokinetics and plasma binding of thiopental. I: Studies in surgical patients
32. Dose-independent pharmacokinetics of fentanyl
33. The biotransformation kinetics of ketamine in vitro in rabbit liver and lung microsome fractions
34. The fate of pentobarbitone and thiopentone in sheep
35. Endotoxin-induced fever increases the clearance of methohexitone in rabbits
36. Pharmacokinetics and clinical experience of 20-h infusions of methohexitone in intensive care patients with postoperative pyrexia
37. Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs
38. Studies on the distribution and metabolism of thiopental in cattle, sheep, goats and swine
39. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of chlorpheniramine and diphenhydramine in rabbits
40. Thipentone pharmacokinetics and electrocorticogram pattern in sheep
41. Pharmacokinetics of alfentanil during and after a fixed rate infusion
42. Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans
43. Dependence of pharmacokinetic parameters on the body weight
44. Pharmacokinetics of ketamine in man